Tag: life sciences
-
Trial Shows Reduction in Huntington Disease Protein
First results from a clinical trial show an experimental therapy reduces production of a protein damaging nerve cells in people with Huntington disease.
-
Start-Up Developing Blood-Brain Barrier Treatments
A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier.
-
Biotech Sponsoring Microbiome-Cancer Research
A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies.
-
Techniques Devised to Boost Gene Therapy Success
An engineering team at Washington University in St. Louis is developing mechanical and electronic processes to improve the success of inserting large, complex therapeutic molecules like DNA into cells.
-
Synthetic Bio Company Starts Up, Raises $53 Million
A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round.
-
Protein Engineered to Boost Nerve Cell Imaging
Engineers and neuroscientists developed a synthetic protein that illuminates electrical activity in animal brain nerve cells, with a process using robotics to test millions of protein candidates in cells.
-
Quick, Portable Soil Pathogen Test Process Developed
A university plant science lab developed techniques with readily-available components and materials that make detecting destructive microbes in farm soil faster and easier.
-
Trials Test Antibodies to Prevent Hospital Infections
Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics.
-
A.I./Image Analysis Diagnose Eye, Lung Diseases
Researchers developed more efficient computational tools with artificial intelligence (A.I.) to diagnose retinal diseases and pneumonia by analyzing retinal scans and X-ray images.
-
Gut-Brain Therapies Biotech Raises $66M in New Funds
A 2 year-old biotechnology enterprise discovering new treatments for disease that harness signals between the gut and brain is raising $66 million its second venture financing round.